NCT00324948View on ClinicalTrials.gov

Topical Alprostadil for Female Sexual Arousal Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

November 30, 2006

Conditions
Sexual Dysfunction, Physiological
Interventions
DRUG

Topical alprostadil (PGE-1)

Trial Locations (2)

94305

Stanford University School of Medicine-Dept of OB/GYN, Stanford

95249

Radiant Research, Cincinnati

All Listed Sponsors
lead

VIVUS LLC

INDUSTRY

NCT00324948 - Topical Alprostadil for Female Sexual Arousal Disorder | Biotech Hunter | Biotech Hunter